Dean R Bender

Title: Dean R Bender: Innovator in Pharmaceutical Chemistry

Introduction

Dean R Bender is a notable inventor based in Hazlet, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 4 patents, showcasing his innovative approaches in the field.

Latest Patents

Among his latest patents is a process for preparing certain aza cyclohexapeptides. This novel process involves the preparation of aza cyclohexapeptides of a specific formula, where all variables are defined in the patent documentation. Another significant patent is for producing 1-beta-methylcarbapenem antibiotic intermediates. This process details the isomerization of an alpha methylated azetidinone alkyl ester to the corresponding beta-methyl isomer, which serves as an intermediate in the synthesis of 1-beta-methylcarbapenem antibacterial agents. The method includes treating the dianion of the alpha isomer with various organic and inorganic compounds, followed by quenching with an appropriate acid.

Career Highlights

Throughout his career, Dean R Bender has worked with prominent organizations such as Merck & Company, Inc. and the University of California. His work in these institutions has significantly contributed to advancements in pharmaceutical research and development.

Collaborations

Dean has collaborated with notable colleagues, including Kevin Michael Belyk and Regina M Black. These partnerships have fostered innovation and progress in their respective fields.

Conclusion

Dean R Bender's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patents and collaborations reflect a commitment to advancing medical science and improving healthcare outcomes.